{"id":"mavik","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Cough","drugRate":"1.9%","severity":"common","organSystem":""},{"effect":"Dizziness","drugRate":"1.3%","severity":"common","organSystem":""},{"effect":"Diarrhea","drugRate":"1%","severity":"common","organSystem":""}],"contraindications":["Acute cerebrovascular insufficiency","Angioedema","Aortic valve stenosis","Bone marrow depression","Bradycardia","Cardiogenic shock","Chronic idiopathic constipation","Complete atrioventricular block","Disease of liver","Disorder of connective tissue","Duchenne muscular dystrophy","First Degree Atrioventricular Heart Block","Hemodialysis with High-Flux Membrane","Hereditary angioneurotic edema","Hyperkalemia","Hypertrophic cardiomyopathy","Hyponatremia","Immunosuppression","Kidney disease","Left heart failure","Liver function tests abnormal","Low blood pressure","Low cardiac output syndrome","Lown-Ganong-Levine syndrome","Myasthenia gravis","Neuromuscular Transmission Deficiency","Neutropenic disorder","Pregnancy, function","Renal artery stenosis","Second degree atrioventricular block","Sick sinus syndrome","Transplantation","Ventricular tachycardia","Wolff-Parkinson-White pattern"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Myocardial infarction","drugRate":"","severity":"serious"},{"effect":"Cardiac failure","drugRate":"","severity":"serious"},{"effect":"Cerebral hemorrhage","drugRate":"","severity":"serious"},{"effect":"Stevens-Johnson syndrome","drugRate":"","severity":"serious"},{"effect":"Toxic epidermal necrolysis","drugRate":"","severity":"serious"},{"effect":"Agranulocytosis","drugRate":"","severity":"serious"},{"effect":"Pancytopenia","drugRate":"","severity":"serious"},{"effect":"Renal failure","drugRate":"","severity":"serious"},{"effect":"Eosinophilic pneumonitis","drugRate":"","severity":"serious"},{"effect":"Hepatitis","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":{"chemblId":"CHEMBL1519","moleculeType":"Small molecule","molecularWeight":"430.55"},"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"bcaffc12-69af-46a8-a092-b3f66a0508d5","title":"MAVIK (TRANDOLAPRIL) TABLET [PHYSICIANS TOTAL CARE, INC.]"},"ecosystem":[],"mechanism":{"target":"Angiotensin-converting enzyme"},"_scrapedAt":"2026-03-28T05:41:30.930Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Chronic heart failure","diseaseId":"chronic-heart-failure","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Hypertensive disorder","diseaseId":"hypertensive-disorder","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Left ventricular cardiac dysfunction","diseaseId":"left-ventricular-cardiac-dysfunction","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07262710","phase":"","title":"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study","status":"NOT_YET_RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2025-12-01","conditions":"Post-stroke Pneumonia","enrollment":13656},{"nctId":"NCT05498675","phase":"","title":"Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2021-09-01","conditions":"Sacubitril/Valsartan, Hypertension, Obesity","enrollment":180},{"nctId":"NCT00840073","phase":"PHASE1","title":"Trandolapril 4 mg Tablet Under Non-Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2004-10","conditions":"Healthy","enrollment":50},{"nctId":"NCT00840632","phase":"PHASE1","title":"Trandolapril 4 mg Tablet Under Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2004-10","conditions":"Healthy","enrollment":40},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT01669434","phase":"PHASE4","title":"Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2015-06-01","conditions":"Hypotension on Induction","enrollment":291},{"nctId":"NCT02817360","phase":"PHASE4","title":"NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients","status":"RECRUITING","sponsor":"Martin Huelsmann","startDate":"2016-02","conditions":"Heart Diseases, Diabetes Mellitus, Type 2","enrollment":2400},{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT04330300","phase":"PHASE4","title":"Coronavirus (COVID-19) ACEi/ARB Investigation","status":"SUSPENDED","sponsor":"National University of Ireland, Galway, Ireland","startDate":"2020-04-30","conditions":"Hypertension, COVID-19","enrollment":2414},{"nctId":"NCT01867047","phase":"NA","title":"ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients","status":"TERMINATED","sponsor":"Duke University","startDate":"2013-06","conditions":"Adverse Effects of Angiotensin-converting-enzyme Inhibitors, Hypotension","enrollment":59},{"nctId":"NCT01715584","phase":"PHASE4","title":"Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics","status":"UNKNOWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2012-07","conditions":"Hypertension","enrollment":80},{"nctId":"NCT01437371","phase":"PHASE3","title":"Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients?","status":"COMPLETED","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2011-08","conditions":"Heart Failure","enrollment":35},{"nctId":"NCT00887510","phase":"PHASE4","title":"Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study)","status":"COMPLETED","sponsor":"University of Florida","startDate":"2007-05","conditions":"Hypertension","enrollment":24},{"nctId":"NCT01078584","phase":"","title":"Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients","status":"COMPLETED","sponsor":"Abbott","startDate":"2008-12","conditions":"Hypertension","enrollment":7993},{"nctId":"NCT00391846","phase":"PHASE4","title":"Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2006-10","conditions":"Heart Failure, Ventricular Dysfunction, Left","enrollment":252},{"nctId":"NCT01127139","phase":"","title":"Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With Tarka® Fixed Combination in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Abbott","startDate":"2010-04","conditions":"Essential Hypertension","enrollment":3828},{"nctId":"NCT00133692","phase":"PHASE4","title":"INVEST: INternational VErapamil SR Trandolapril STudy","status":"COMPLETED","sponsor":"University of Florida","startDate":"1997-09","conditions":"Hypertension, Coronary Artery Disease","enrollment":22000},{"nctId":"NCT01164787","phase":"PHASE1","title":"Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fasting Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2006-03","conditions":"Healthy","enrollment":52},{"nctId":"NCT01164800","phase":"PHASE1","title":"Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fed Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2006-03","conditions":"Healthy","enrollment":52},{"nctId":"NCT00252317","phase":"PHASE4","title":"Acute Haemodynamic Effects of Treatment With Angiotensin Converting Enzyme (ACE)-Inhibitors in Patients With Symptomatic Aortic Stenosis","status":"UNKNOWN","sponsor":"Rigshospitalet, Denmark","startDate":"2005-11","conditions":"Aortic Stenosis","enrollment":64},{"nctId":"NCT00233532","phase":"PHASE4","title":"Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)","status":"COMPLETED","sponsor":"Abbott","startDate":"2004-03","conditions":"Hypertension","enrollment":2000},{"nctId":"NCT00234871","phase":"PHASE4","title":"Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)","status":"COMPLETED","sponsor":"Abbott","startDate":"2004-01","conditions":"Hypertension, Diabetes, Proteinuria","enrollment":357},{"nctId":"NCT00234858","phase":"PHASE4","title":"Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)","status":"COMPLETED","sponsor":"Abbott","startDate":"2004-03","conditions":"Hypertension, Metabolic Syndrome","enrollment":280},{"nctId":"NCT00235014","phase":"PHASE4","title":"A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)","status":"COMPLETED","sponsor":"Abbott","startDate":"1997-03","conditions":"Hypertension, Diabetes","enrollment":1204},{"nctId":"NCT00235001","phase":"PHASE4","title":"Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension","status":"COMPLETED","sponsor":"Abbott","startDate":"2004-06","conditions":"Hypertension","enrollment":120},{"nctId":"NCT00684489","phase":"NA","title":"Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2003-09","conditions":"Hypertension","enrollment":52},{"nctId":"NCT00679653","phase":"PHASE3","title":"Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives","status":"COMPLETED","sponsor":"Abbott","startDate":"2002-02","conditions":"Obesity, Hypertension","enrollment":171}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Cardiovascular"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Mavik","genericName":"Mavik","companyName":"Dr. Reddy's Laboratories Limited","companyId":"dr-reddy-s-laboratories-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}